Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 10Terminated 4Withdrawn 2Unknown 2Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Plasma cell 1

Conditions

Pain 2Neoplasm Metastasis 2Bone Neoplasms 2Multiple Myeloma 1Lung Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Interventional × Ibandronic Acid × Clear all
NCT00099177 2017-08-16

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Hoffmann-La Roche

Phase 3 Terminated
96 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT00099203 2017-08-16

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Hoffmann-La Roche

Phase 3 Terminated
163 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT02739594 2016-07-22

COMPARE

Hoffmann-La Roche

Phase 3 Terminated
89 enrolled 17 charts
Plasma cell

Multiple Myeloma

NCT00492843 2016-02-17

Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis

Chinese Society of Lung Cancer

Phase 4 Terminated
20 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡